Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02864329 · ClinicalTrials.gov registry record

Small RNA Pathways in Mammalian Gametogenesis

A clinical trial of Male Infertility, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
182
Enrollment target
1
Study location

NCT02864329 is a study of Male Infertility that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 182 participants, below the 535-participant average among 8 other Male Infertility trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02864329, a study of Male Infertility, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
182 participants
Enrollment target
1
Study location

Study Summary

Basic and clinical research is revealing that various noncoding and small RNAs play important and diverse roles in germ cell development and quality, including X/Y silencing during meiosis, gene regulation, DNA damage responses, and protection of the genome against transposable elements. Indeed, mammalian germ cells are known to harbor multiple small RNA species, including small interfering RNAs (siRNA), microRNAs (miRNA), and germline- specific PIWI- interacting RNAs (piRNA). However, their mechanistic roles in gametogenesis and human infertility are largely uncharacterized. The goal of this study is to elucidate the role of small RNA pathways in the events that give rise to viable euploid gametes. Four projects and three cores are included in this study.

Conditions Studied

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2014-04
Est. Completion 2024-03-20

What the Registry Record Tells You About NCT02864329

The ClinicalTrials.gov registry entry for NCT02864329 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 535-participant average among 8 other Male Infertility trials with a reported enrollment target (66% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Male Infertility appearing as the primary indexed condition, and to 0 interventions.

NCT02864329 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02864329 about?

NCT02864329 is a clinical study titled "Small RNA Pathways in Mammalian Gametogenesis". Basic and clinical research is revealing that various noncoding and small RNAs play important and diverse roles in germ cell development and quality, including X/Y silencing during meiosis, gene regulation, DNA damage responses, and protection of the genome against transposable elements. Indeed, mam...

What is the current status of trial NCT02864329?

This trial is currently completed. The enrollment target is 182 participants. The study started on 2014-04. Estimated completion is 2024-03-20.

What conditions does trial NCT02864329 study?

This clinical trial studies the following conditions: Male Infertility.

Who is sponsoring clinical trial NCT02864329?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02864329 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Male Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.